Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease

被引:2
|
作者
Keleman, Audrey A. [1 ]
Nicosia, Jessica y [2 ]
Bollinger, Rebecca M. [1 ]
Wisch, Julie K. [2 ]
Hassenstab, Jason [2 ,3 ]
Morris, John C. [2 ,5 ]
Ances, Beau M. [2 ,4 ,5 ]
Balota, David A. [3 ]
Stark, Susan L. [1 ,2 ]
机构
[1] Washington Univ St Louis, Program Occupat Therapy, St Louis, MO USA
[2] Washington Univ St Louis, Dept Neurol, St Louis, MO USA
[3] Washington Univ St Louis, Dept Psychol, St Louis, MO USA
[4] Washington Univ St Louis, Dept Radiol, St Louis, MO USA
[5] Washington Univ St Louis, Hope Ctr Neurol Disorders, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; cognition; falls; functional mobility; DWELLING OLDER-PEOPLE; RISK-FACTORS; DATA SET; GAIT SPEED; PERFORMANCE; VALIDATION; VERSION; HEALTH; TAU; PREDICTOR;
D O I
10.3233/ADR-230002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Individuals with Alzheimer's disease (AD) are more than twice as likely to incur a serious fall as the general population of older adults. Although AD is commonly associated with cognitive changes, impairments in other clinical measures such as strength or functional mobility (i.e., gait and balance) may precede symptomatic cognitive impairment in preclinical AD and lead to increased fall risk. Objective: To examine mechanisms (i.e., functional mobility, cognition, AD biomarkers) associated with increased falls in cognitively normal older adults. Methods: This 1-year study was part of an ongoing longitudinal cohort study. We examined the relationships among falls, clinical measures of functional mobility and cognition, and neuroimaging AD biomarkers in cognitively normal older adults. We also investigated which domain(s) best predicted fall propensity and severity through multiple regression models. Results: A total of 182 older adults were included (mean age 75 years, 53% female). A total of 227 falls were reported over the year; falls per person ranged from 0-16 with a median of 1. Measures of functional mobility were the best predictors of fall propensity and severity. Cognition and AD biomarkers were associated with each other but not with the fall outcome measures. Conclusion: These results suggest that, although subtle changes in cognition may be more closely associated with AD neuropathology, functional mobility indicators better predict falls in cognitively normal older adults. This study adds to our understanding of the mechanisms underlying falls in older adults and could lead to the development of targeted fall prevention strategies.
引用
收藏
页码:739 / 750
页数:12
相关论文
共 50 条
  • [1] Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
    Bollinger, Rebecca M.
    Keleman, Audrey
    Thompson, Regina
    Westerhaus, Elizabeth
    Fagan, Anne M.
    Benzinger, Tammie L. S.
    Schindler, Suzanne E.
    Xiong, Chengjie
    Balota, David
    Morris, John C.
    Ances, Beau M.
    Stark, Susan L.
    BMJ OPEN, 2021, 11 (09):
  • [2] Preclinical Alzheimer disease and risk of falls
    Stark, Susan L.
    Roe, Catherine M.
    Grant, Elizabeth A.
    Hollingsworth, Holly
    Benzinger, Tammie L.
    Fagan, Anne M.
    Buckles, Virginia D.
    Morris, John C.
    NEUROLOGY, 2013, 81 (05) : 437 - 443
  • [3] Falls and age in patients with Alzheimer's disease
    Bassiony, MM
    Rosenblatt, A
    Baker, A
    Steinberg, M
    Steele, CD
    Sheppard, JME
    Lyketsos, CG
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2004, 192 (08) : 570 - 572
  • [4] Preclinical Alzheimer's disease
    Gil-Gregorio, P.
    Yubero-Pancorbo, R.
    REVIEWS IN CLINICAL GERONTOLOGY, 2014, 24 (02) : 117 - 121
  • [5] Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease
    Ho, Jean K.
    Nation, Daniel A.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2018, 24 (07) : 693 - 702
  • [6] Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
    Chatterjee, Pratishtha
    Pedrini, Steve
    Ashton, Nicholas J.
    Tegg, Michelle
    Goozee, Kathryn
    Singh, Abhay K.
    Karikari, Thomas K.
    Simren, Joel
    Vanmechelen, Eugeen
    Armstrong, Nicola J.
    Hone, Eugene
    Asih, Prita R.
    Taddei, Kevin
    Dore, Vincent
    Villemagne, Victor L.
    Sohrabi, Hamid R.
    Zetterberg, Henrik
    Masters, Colin L.
    Blennow, Kaj
    Martins, Ralph N.
    ALZHEIMERS & DEMENTIA, 2022, 18 (06) : 1141 - 1154
  • [7] Salient Cognitive Paradigms to Assess Preclinical Alzheimer's Disease
    Cid, Rosie E. Curiel
    Loewenstein, David A.
    NEUROTHERAPEUTICS, 2022, 19 (01) : 89 - 98
  • [8] Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease
    Yakoub, Yara J.
    Ashton, Nicholas
    Strikwerda-Brown, Cherie
    Montoliu-Gaya, Laia K.
    Karikari, Thomas
    Kac, Przemyslaw R.
    Gonzalez-Ortiz, Fernando
    Gallego-Rudolf, Jonathan
    Meyer, Pierre-Francois
    St-Onge, Frederic
    Schoell, Michael
    Soucy, Jean-Paul
    Breitner, John C. S.
    Zetterberg, Henrik
    Blennow, Kaj
    Poirier, Judes
    Villeneuve, Sylvia
    ALZHEIMERS & DEMENTIA, 2023, : 5620 - 5631
  • [9] Cognitive deficits in preclinical Alzheimer's disease
    Small, BJ
    Mobly, JL
    Laukka, EJ
    Jones, S
    Bäckman, L
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 : 29 - 33
  • [10] Risk of falls in Alzheimer's disease: A prospective study
    Horikawa, E
    Matsui, T
    Arai, H
    Seki, T
    Iwasaki, K
    Sasaki, H
    INTERNAL MEDICINE, 2005, 44 (07) : 717 - 721